Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma

American Journal of Clinical Pathology

Volumn 116, Issue 6, 2001, Pages 838-845

  Ng, I O L ^a   Poon, R T P ^a   Lee, J M F ^a   Fan, S T ^a   Ng, M ^a   Tso, W K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Flk 1 KDR; Flt 1; Hepatocellular carcinoma; Microvessel density; Vascular endothelial growth factor; VEGF

Indexed keywords

ANTIBODY; CD34 ANTIGEN; ISOPROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DENSITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MICROVASCULATURE; PRIORITY JOURNAL; TUMOR GROWTH;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DNA PRIMERS; DNA, NEOPLASM; ENDOTHELIAL GROWTH FACTORS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; LYMPHOKINES; MALE; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035190559     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/FXNL-QTN1-94FH-AB3A     Document Type: Article

References (33)

1. The role of angiogenesis in tumor growth
2. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
3. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells
4. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
5. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer
6. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, plateletderived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis
7. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma
8. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms
9. A novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression
10. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade
11. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1)
12. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor
13. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma
14. Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma
15. Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma: An immunohistochemical study
16. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver
17. Expression of vascular endothelial growth factor in human hepatocellular carcinoma
18. Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma
19. Vascular endothelial growth factor/vascular permeability factor mRNA expression in patients with chronic hepatitis C and hepatocellular carcinoma
20. Tumor angiogenesis and metastasis: Correlation in invasive breast cancer
21. Quantitation of sinusoidallike vessels in hepatocellular carcinoma: Its clinical and prognostic significance
22. Prognostic significance of pathologic features of hepatocellular carcinoma: A multivariate analysis of 278 patients
23. Primary carcinoma of the liver: A study of 100 cases among 48900 necropsies
24. Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor
25. Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis
26. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice
27. The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus
28. Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma
29. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer
30. Flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors
31. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma
32. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis
33. Increased expressions of vascular endothelial growth factor and its receptors, flt-1 and KDR/flk-1, in regenerating rat liver